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the role of Mannose Binding Lectin 
in the immune response against 
Borrelia burgdorferi sensu lato
Jeroen Coumou1, Alex Wagemakers  1, sukanya Narasimhan2, tim J. schuijt1, 
Jasmin I. ersoz1, Anneke oei3, onno J. de Boer4, Joris J. t. H. Roelofs4, erol Fikrig2 & 
Joppe W. Hovius1
the causative agents of Lyme borreliosis, spirochetes belonging to the Borrelia burgdorferi sensu lato 
group, have developed several ways to protect themselves against killing by the host complement 
system. In addition, it has been shown that serum sensitive isolates are (partially) protected by the 
Ixodes tick salivary Lectin pathway Inhibitor (tsLpI) protein; a salivary gland protein that inhibits the 
function of Mannose Binding Lectin (MBL). MBL is a C-type lectin that recognizes oligosaccharides 
on pathogens and activates the complement system via the lectin pathway. MBL deficiency has been 
linked to a more severe course of several infectious diseases and humans with detectable antibodies 
against B. burgdorferi are significantly more often MBL deficient compared to humans without 
antibodies against B. burgdorferi. Here we set out to investigate the role of MBL in the immune 
response against B. burgdorferi in more detail. We demonstrate that B. burgdorferi N40 needle-infected 
C57BL/6 MBL deficient mice harbored significantly higher B. burgdorferi numbers in skin tissue during 
the early course of infection. In line with these findings they also developed higher anti-B. burgdorferi 
IgG serum antibodies compared to Wt controls. In contrast, B. burgdorferi loads in distant tissue such 
as heart, joints or bladder at later time points were similar for both mouse strains. these in vivo findings 
were corroborated using a B. burgdorferi N40-infected I. scapularis infestation model. We showed that 
MBL is capable of binding B. burgdorferi through its carbohydrate recognition domains, but  
in vitro complement killing assays, peritoneal macrophage and whole blood stimulations, phagocytosis 
assays and an in vivo migration experiment did not reveal the mechanism by which MBL facilitates early 
clearance of B. burgdorferi. to conclude, we show a protective role of MBL in the early stages of  
B. burgdorferi infection, yet the underlying mechanism warrants further investigation.
The causative agents of Lyme borreliosis (LB), spirochetes belonging to the Borrelia burgdorferi sensu lato group, 
are transmitted by Ixodes ticks1. Since 1981 multiple Borrelia species have been identified as the causative agents 
of LB and are being referred to as B. burgdorferi sensu lato (s.l.). In the USA, B. burgdorferi is the predominant 
prevalent agent for LB, whereas in Europe B. afzelii and B. garinii are the main causative agents of LB2,3. Infection 
with B. burgdorferi s.l. can lead to erythema migrans (EM) at the tick bite site after which dissemination to other 
skin sites or to the heart, joint or the central nervous system can occur4.
During transmission and dissemination, B. burgdorferi s.l. has developed several ways to evade and modulate 
the host’s innate and adaptive immune responses5. Among these mechanisms are the exploitation of immunosup-
pressive tick proteins and the ability to suppress activation of the complement system6. The complement system 
consists of approximately 30 proteins and its main functions are killing of pathogens by lysis through the mem-
brane attack complex (MAC), activation and attraction of leukocytes and opsonisation of pathogens for phagocy-
tosis by leukocytes7. The complement system can be activated via three different pathways; the classical pathway, 
the lectin pathway and the alternative pathway. B. burgdorferi s.l. is able to suppress activation of the complement 
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system via expression of complement regulation proteins on its extracellular membrane such as complement 
regulator acquiring surface proteins (CRASPs), CD59 like proteins and C4b-binding proteins6,8–10. The expres-
sion of these proteins varies between different B. burgdorferi s.l. strains, making some strains more susceptible to 
eradication by the complement system than others11.
We have previously demonstrated the role of the lectin pathway in the immune response against B. burgdorferi 
by the identification and characterisation of the tick salivary gland protein Tick Salivary Lectin Pathway Inhibitor 
(TSLPI)12. In vitro experiments revealed that I. scapularis as well as I. ricinus TSLPI was able to specifically inhibit 
the lectin pathway by binding to MBL - resulting in decreased complement-dependent killing of B. burgdorferi by 
human serum12,13. Furthermore, phagocytosis of B. burgdorferi by human neutrophils was decreased, as well as 
B. burgdorferi transmission to mice by ticks in which TSLPI was silenced.
MBL is a soluble pattern-recognition molecule, which can activate the lectin pathway after binding to oligo-
saccharides on the surface of pathogens. Furthermore, opsonisation of MBL to pathogens initiates phagocytosis 
by leukocytes, as well as cytokine responses independent of complement activation14. Around 20–25% of the 
human population is MBL deficient or has low MBL levels (defined as <500 ng/mL in serum)15,16. Studies have 
shown that MBL deficiency can result in increased susceptibility to infections, in particular in patients in whom 
the adaptive immune system is suppressed or immature17. On the contrary, MBL deficiency also seems to have 
a protective role against adversarial effects of the immune response, such as tissue damage caused by activation 
of the complement system18. Others have shown that MBL deficiency correlated with the presence of antibodies 
against B. burgdorferi s.l. in human sera19. Although seropositivity for antibodies against B. burgdorferi s.l. does 
not necessarily indicate active Lyme borreliosis, these findings support the theory that MBL deficient individuals 
have a higher risk of contracting LB.
To elucidate the role of MBL deficiency in the immune response against B. burgdorferi s.l. we performed 
experiments with wildtype (WT) C57BL/6 mice and a C57BL/6 mouse strain that is deficient for MBL20. Whereas 
humans express one type of MBL, mice express two types of MBL, namely MBL-A and MBL-C21. Studies with the 
double knock-out MBL-A and -C deficient mice have shown the protective role of MBL against several pathogens, 
i.e. S. aureus, P. aeruginosa, C. albicans and others, as well as the benefit of MBL deficiency in tissue injury caused 
by complement activation22. In this study we infected wild type (WT) C57BL/6 mice and double knock-out 
MBL-A and -C C57BL/6 mice with B. burgdorferi and monitored B. burgdorferi tissue loads and histopathological 
changes to determine the role of MBL in vivo. Furthermore, we set out to determine the role of MBL deficiency 
in specific innate immune responses against B. burgdorferi, such as complement killing assays, peritoneal mac-
rophage and whole blood stimulations, phagocytosis assays and in vivo migration assays.
Results
MBL levels in LB patients versus healthy controls. Others have correlated MBL deficiency to be more 
prevalent in individuals with detectable B. burgdorferi s.l. antibodies in serum19. To further investigate whether 
MBL deficiency indeed plays a role in the risk of contracting B. burgdorferi s.l. infection or LB, we compared MBL 
levels in serum from LB patients to those of healthy controls. MBL levels were measured by an enzyme-linked 
immunosorbant assay (ELISA) of 31 patients with erythema migrans (localized disease), 33 patients with neu-
roborreliosis or ACA (late or disseminated disease), and 31 healthy controls. We found comparable levels of MBL 
in all three groups (Fig. 1).
MBL deficient mice harbor higher dermal B. burgdorferi loads compared to Wt mice. To more 
specifically determine the role of MBL during B. burgdorferi s.l. infection, we compared B. burgdorferi survival 
in the murine host using MBL deficient C57BL/6 mice and WT C57BL/6 mice. Mice were infected subcuta-
neously with 106 B. burgdorferi N40 and after 14 days of infection B. burgdorferi infection in skin and dissem-
inated organs was measured by quantitative Polymerase Chain Reaction (qPCR). In addition, we determined 
antibody responses against B. burgdorferi in serum. Interestingly, mice lacking MBL had significantly higher 
loads of B. burgdorferi in skin after 14 days (Fig. 2A). Furthermore, higher titers of anti-B. burgdorferi IgG and 
IgM were observed in serum of MBL deficient mice compared to WT mice (Fig. 2B). However, B. burgdorferi 
numbers in deeper tissue (heart, joint and bladder) were similar between both mouse strains (Fig. 2C). Culture 
of skin and bladder confirmed live spirochetes but showed no difference between WT and mice lacking MBL 
(Supplemental Table 1). To support these findings, we also challenged WT and MBL deficient mice with B. burg-
dorferi N40-infected I. scapularis nymphs in an independent experiment (Fig. 2D,E). There were no significant 
differences in post-feeding tick weights or B. burgdorferi burden in the ticks (data not shown). Interestingly, 
we again observed significantly higher loads of B. burgdorferi in MBL deficient mice at an early time point the 
tick bite site (Fig. 2D), but we did not find any differences in dissemination of B. burgdorferi to deeper tissue at 
a later time point between both mouse strains (Fig. 2E). Higher numbers of spirochetes, based on flaB/B-actin 
copies, were observed in mice infected by ticks compared to needle inoculation. We speculate this is because of a 
difference in viability and survival of B. burgdorferi spirochetes transmitted by ticks compared to B. burgdorferi 
spirochetes that have been grown in vitro in BSK medium. We also compared histological signs of inflammation 
in B. burgdorferi-infected organs in the mice infected by needle inoculation. Signs of arthritis were mild or absent 
and no differences between WT and MBL deficient mice were observed (data not shown). In contrast, all B. 
burgdorferi-infected mice developed carditis, but WT and MBL deficient mice had a similar score for inflamma-
tion (Fig. 2F,G). Control animals injected with PBS alone did not display carditis (Fig. S1).
MBL binds to B. burgdorferi but is not crucial in killing of B. burgdorferi by murine serum. To 
elucidate how MBL deficiency results in higher B. burgdorferi survival, we performed several in vitro experiments 
to study the role of MBL in several innate immune responses against B. burgdorferi. We first determined whether 
MBL directly interacts with B. burgdorferi. Indeed, binding of recombinant human MBL to B. burgdorferi was 
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observed using flow cytometry (Fig. 3A). This was abrogated in the presence of 100 mM EDTA, which suggests 
that MBL binds to B. burgdorferi in calcium dependent fashion via its carbohydrate recognition domains (CRDs). 
Next, we assessed whether murine native MBL was able to bind to B. burgdorferi membrane proteins using an 
ELISA coated with extracellular B. burgdorferi N40 extracts. We observed a dose-dependent increase in binding 
of MBL-A to extracellular B. burgdorferi extracts using normal murine serum (NMS), which we did not observe 
in MBL deficient murine serum or in NMS pre-incubated with 100 mM EDTA, suggesting that also MBL-A binds 
to B. burgdorferi membrane proteins via its CRDs (Fig. 3B).
We have previously shown that B. burgdorferi is partially protected from killing by human serum in the pres-
ence of a neutralizing antibody against human MBL, as well as in human MBL deficient serum12. We therefore 
hypothesized that murine serum lacking MBL would have impaired complement-dependent killing of B. burgdor-
feri. For this we used a growth inhibition assay, which has been used previously to study complement-dependent 
killing of B. burgdorferi12,23. B. burgdorferi N40 was incubated in 50% normal mouse serum (NMS) or 50% 
heat-inactivated (HI) mouse serum of either WT or MBL deficient mice. We found that active mouse complement 
was able to inhibit the growth of B. burgdorferi N40, as no decrease in absorbance was observed after five days in 
contrast to heat-inactivated serum (Fig. 3C). No difference in growth inhibition was however observed between 
MBL deficient and WT NMS (Fig. 3C). Next, we determined the percentage of dead (non-motile) spirochetes by 
dark-field microscopy after incubation of B. burgdorferi with serum at 37 °C. We demonstrated that all spirochetes 
remained motile after 1.5 h and 4 h of incubation with 50% WT NMS or MBL deficient serum using B. burgdorferi 
N40 (data not shown). Both experiments were also performed with B. garinii A87S, a strain which is known to 
be sensitive to complement-dependent killing. Growth inhibition by NMS was observed for B. garinii A87S, but 
this was again similar when MBL deficient serum was used (Fig. 3D). Dark-field microscopy showed that WT 
murine serum was indeed able to kill B. garinii spirochetes (Fig. 3E), however the percentage of non-motile B. 
garinii spirochetes by dark-field microscopy were comparable for both WT and MBL deficient serum. Together 
these data suggest that the higher B. burgdorferi loads observed in MBL deficient mice are unlikely to be due to 
impaired killing by the complement system in MBL deficient mice.
MBL deficient mice have a similar inflammatory cytokine response upon stimulation with B. 
burgdorferi compared to Wt mice. Since we did not find differences in complement-dependent killing 
between WT and MBL deficient murine serum in vitro, we hypothesized that lower pro-inflammatory and/or 
increased immunomodulatory cytokine responses could be responsible for the observed increased B. burgdorferi 
survival in vivo. Therefore, we assessed the levels of cytokines in the supernatant of murine whole blood upon 
stimulation with B. burgdorferi N40. Measurement of cytokine levels by cytometric bead array (CBA) after 16 h 
of incubation showed that levels of TNF-alpha, IL-6 and MCP-1 in whole blood were increased in the presence 
of B. burgdorferi compared to medium only, whereas IFN-gamma and IL-12p70 levels were below detection limit 
(Fig. 4A and Table S2 for the medium only). However, we did not find any differences comparing cytokine levels 
of MBL deficient mice to WT mice (Fig. 4A). These findings were corroborated using murine macrophages. 
In addition, WT peritoneal macrophages were collected and allowed to adhere overnight and incubated with 
Figure 1. MBL levels in Lyme borreliosis patients versus healthy controls. MBL levels in serum from Lyme 
borreliosis (LB) patients with confirmed erythema migrans (EM) or disseminated LB (Lyme neuroborreliosis or 
acrodermatitis chronica atrophicans (LNB + ACA) and in healthy controls previously collected at our institute 
were measured using an ELISA coated with mannan. Bound serum MBL was detected by a mouse anti- human 
MBL antibody. The mean of MBL levels in serum from 31 patients with EM was 2.04 µg/mL and in 33 patients 
with LNB or ACA 1.96 µg/mL, compared 1.98 µg/mL in 31 healthy controls. Percentages of MBL deficiency per 
group (determined as <500 µg/mL) were 15.6% (n = 5) for erythema migrans, 12.1% (n = 4) for LNB and ACA, 
and 22.6% (n = 7) for healthy controls. Error bars represent the mean ± SEM.
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B. burgdorferi in the presence of WT or MBL deficient serum. Comparing cytokine levels in the presence of 20% 
WT or MBL deficient serum to medium without serum showed that serum components were found to be cru-
cial for the production of IL-6 and MCP-1, but not TNF-alpha, by murine macrophages upon stimulation with 
Figure 2. Increased B. burgdorferi burden in skin tissue but not in other tissues of MBL deficient mice during 
murine B. burgdorferi infection. (A–C) WT and MBL deficient mice (8 per group) were infected with 106 B. 
burgdorferi N40 via subcutaneous inoculation. Mice were sacrificed after 14 days and assessed for B. burgdorferi 
burden. DNA was extracted using the Qiagen Blood and Tissue kit from skin, heart, joint and bladder and 
were subjected to quantitative B. burgdorferi flaB PCR normalized for quantitative mouse β-actin PCR. A. 
qPCR assessment of B. burgdorferi burden in skin after 14 days. (B) IgG and IgM titers against B. burgdorferi 
lysate in serum measured by ELISA. (C) qPCR assessment of B. burgdorferi burden in joint, bladder or heart. 
(D,E) WT and MBL deficient mice (8 per group) were infected with B. burgdorferi N40 via a tick challenge 
(4–5 ticks/mouse). Two separate experiments were performed, one with three animals per group and one 
with five animals per group. B. burgdorferi burden was normalized to the highest WT control value per 
experiment to pool both experiments. (D) qPCR assessment of B. burgdorferi burden in skin from ear biopsy 
at 7 days. (E) qPCR assessment of B. burgdorferi burden in skin, joint, bladder or heart at 21 days. (F,G) Five 
µm-thick sagittal heart sections were stained with hematoxylin and eosin. A carditis score was performed 
by an independent pathologist who was blinded to the experimental design on a scale from 0–3 with 0 being 
no, 1 mild, 2 moderate, and 3 being severe carditis. Carditis was characterized by disperse inflammation at 
the atrioventricular junction and aortic root. See Fig. S1 for a normal heart from a mice injected with PBS 
as a control. Error bars represent mean ± SEM and mean values significantly different in a two-tailed non-
parametric Mann-Whitney test are indicated by asterisks (*p < 0.05 and **p < 0.01).
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B. burgdorferi (Fig. 4B–D). IFN-gamma and IL-12p70 levels were again below detection limit (data not shown). 
However, in line with the whole blood experiments, we found similar levels of TNF-alpha, IL-6 and MCP-1 in 
the presence of WT or MBL deficient serum. Together these data indicate that the higher B. burgdorferi loads 
observed in MBL deficient mice are unlikely to be due to altered cytokine responses in MBL deficient mice.
MBL deficiency does not play a role in B. burgdorferi phagocytosis by murine neutrophils or 
peritoneal macrophages. Another function of the innate immune response by which MBL could 
be involved in the immune response against B. burgdorferi is phagocytosis by neutrophils or macrophages. 
Interestingly, we previously found that in the presence of TSLPI, phagocytosis of B. burgdorferi by human gran-
ulocytes was decreased12. To determine whether MBL deficiency would result in decreased phagocytosis, we 
collected murine whole blood from MBL and WT mice and added CFSE-labeled viable B. burgdorferi N40 to a 
multiplicity of infection (MOI) of 10. Phagocytosis of B. burgdorferi by murine neutrophils (Ly6 positive cells) 
Figure 3. MBL binds to B. burgdorferi, but MBL deficiency in mice does not decrease complement-dependent 
killing of B. burgdorferi. (A) Recombinant human MBL (5 µg/mL) was added to cultured CFSE-labeled  
B. burgdorferi N40 spirochetes (2 × 108 spirochetes/mL) and after two washing steps, binding of MBL to  
B. burgdorferi was subjected to FACS analysis (red line). As a control, 100 mM EDTA was added together with 
MBL which abrogates calcium dependent binding of MBL CRD’s (yellow dotted line). The blue line represents 
spirochetes without MBL. Binding of MBL was determined using a mouse anti-human MBL antibody and a 
goat anti-mouse IgG Texas Red antibody. (B) ELISA assessment of dose-dependent binding of MBL in murine 
serum to B. burgdorferi membrane protein extract-coated plates. WT serum or MBL deficient murine serum 
was added to wells and murine MBL was detected using an antibody against murine MBL-A. As a control, 
normal murine serum was pre-incubated with 100 mM EDTA. (C) Growth inhibition of B. burgdorferi strain 
N40 by murine serum was measured by the color change of Phenol Red at 562/630 nm once a day for up to five 
days. Ratio NMS/HI NMS and MBL deficient serum/HI MBL deficient serum after five days was 3.66 and 3.01, 
respectively. (D) Growth inhibition of B. garinii strain A87S by murine serum. The ratio NMS/HI NMS and 
MBL deficient serum/HI MBL deficient serum after five days was 2.84 and 2.86, respectively. (E) B. garinii strain 
A87S was incubated with 25% WT NMS, 25% MBL deficient murine serum or 25% heat-inactivated (HI) NMS 
(control). After 1 h of incubation the percentages of non-motile spirochetes were determined by a researcher 
blinded to the experimental design. Each sample and each time point were performed in triplicates and symbols 
or bars represent the mean ± SEM.
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after 5, 15 and 30 minutes at 37 °C was measured by flow cytometry, as previously described12. No significant dif-
ference in phagocytosis of B. burgdorferi N40 was observed between MBL deficient murine whole blood and WT 
murine whole blood (Fig. 5A). To support our findings, we also investigated opsonophagocytosis by WT murine 
macrophages collected from peritoneal lavage fluid in the presence of 10% serum from WT or MBL deficient 
mice. Although we observed a dose-dependent increase of phagocytosis in the presence of WT murine serum 
after 30 minutes of incubation at 37 °C (Fig. S2), we did not observe a difference in phagocytosis by WT murine 
peritoneal macrophages in the presence of WT or MBL deficient serum (Fig. 5B). Together these data indicate 
that the higher B. burgdorferi loads observed in MBL deficient mice are unlikely to be due to altered opsono-
phagocytosis in MBL deficient mice.
Early inflammation in vivo during B. burgdorferi infection is not impaired by MBL deficiency. We next 
analyzed by an in vivo migration experiment whether the higher burden of Borrelia measured in murine skin in 
the absence of MBL is the result of an impaired inflammatory response in the early phase of a Borrelia infection. 
Therefore, we inoculated C57BL/6 WT and MBL deficient mice with B. burgdorferi or PBS as a control and har-
vested skin at 6 hours post infection. We scored inflammation in H&E staining of sagittal skin sections on a score 
of 0–3. In line with what we have previously described24, inoculation of spirochetes by itself resulted in inflam-
mation, as can also be appreciated by comparison to the control groups. However, inoculating Borrelia resulted 
in a higher, but comparable, inflammation score for both WT and MBL deficient mice at t = 6 hours (Fig. 5C).
Figure 4. Levels of cytokines upon in vitro stimulation with B. burgdorferi N40 are similar between MBL 
deficient mice and WT control. (A) TNF-alpha, IL-6, MCP-1, IFN-y and IL-12p70 levels in the supernatant 
of murine whole blood stimulated with B. burgdorferi N40 (MOI: 5) for 16 h. Cytokines levels were measured 
using a mouse inflammation cytometric bead array (CBA), see also Table S2. As a control, whole blood was 
incubated in RPMI medium. Detection range: 2.5–10.000 pg/mL. (B,D) A similar experiment was performed 
with murine macrophages collected from peritoneal lavage fluid. 50.000 macrophages were stimulated with 
B. burgdorferi (MOI: 5) for 16 h in the presence of 20% WT serum or MBL deficient serum. Samples without 
serum and samples with serum only were used as control. Levels of TNF-alpha (B), IL-6 (C) and MCP-1 (D) 
are shown, IFN-y and IL-12p70 levels were below detection limit. Samples were performed in triplicates and the 
experiment was performed twice. Symbols or bars represent the mean ± SEM.
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Discussion
Previously we have shown that the lectin pathway, which can be activated by MBL, is important for the innate 
immune response against B. burgdorferi12. Inhibition of MBL by the tick protein TSLPI resulted in decreased 
complement-depended killing and phagocytosis by human neutrophils. Furthermore, others have found that 
MBL deficiency was more often present in individuals with antibodies against B. burgdorferi s.l. in serum com-
pared to B. burgdorferi s.l. seronegative individuals19. However, the presence of antibodies does not equal disease. 
Therefore, we determined MBL levels in Lyme borreliosis patients and healthy controls and we showed that levels 
of MBL in patients with active B. burgdorferi s.l. infection were similar to MBL levels in healthy controls, although 
it should be mentioned we have only investigated a small number of patients and controls. In our opinion, it still 
remains to be determined whether MBL deficiency in humans is truly associated with a higher risk of infection 
with B. burgdorferi s.l. It could also be that impaired recognition of B. burgdorferi s.l. in MBL deficient individuals 
protects them against developing (severe) LB manifestations. This duality has been shown for TLR-2, where a 
Figure 5. Phagocytosis of B. burgdorferi and inflammation in vivo during early infection are similar between 
MBL deficient mice and WT control. (A) Phagocytosis of B. burgdorferi by murine neutrophils in whole blood. 
Whole blood samples from five mice were subjected to FACS analysis after 5, 15 and 30 min of incubation 
at 37 °C with CFSE-labeled viable B. burgdorferi N40. Neutrophils were gated using rat-anti mouse Ly6 
antibodies and the phagocytosis was calculated by the mean fluorescence x percentage of positive neutrophils 
(phagocytosis index). Samples kept on ice were used as baseline. (B) A second phagocytosis experiment was 
also performed with macrophages collected from peritoneal fluid from WT mice. Macrophages (50.000 per 
sample) were incubated with 10% WT serum or MBL deficient serum and B. burgdorferi N40 spirochetes 
(MOI:25). Phagocytosis of CFSE-labeled viable B. burgdorferi N40 by murine macrophages was determined by 
FACS analysis and expressed as phagocytosis index. Both the experiments in (A,B) are a representative of two 
independent experiments, samples were performed in triplicates. Bar or symbols represent the mean ± SEM 
(C). Inflammation based on scoring of H&E staining of skin 6 hours after inoculation of B. burgdorferi. WT: 
wildtype mouse, MBL −/−: MBL deficient mouse. Bb: experimental groups in which B. burgdorferi N40 was 
injected intradermally (106 spirochetes per mice in 10 uL). PBS: control groups (n = 2) in which 10 uL PBS was 
injected intradermally. The experiment was performed twice. Error bars represent mean ± SEM.
www.nature.com/scientificreports/
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heterozygous Arg753Gln polymorphism was found to result in a decreased in vitro immune response against B. 
burgdorferi N40 lysate and this polymorphism was less often present in patients with late stage LB25.
To further elucidate the role of MBL during B. burgdorferi infection in vivo, we performed experiments with 
WT mice and mice that lack MBL. We demonstrated that murine MBL is able to bind to B. burgdorferi, and that 
compared to WT mice MBL deficient mice have higher B. burgdorferi loads in skin tissue at the inoculation or 
tick bite site. Besides higher dermal loads we also found higher anti-B. burgdorferi antibody titers in serum of 
MBL deficient mice, which are known to correlate well with spirochetal burden26. However, no increase in B. 
burgdorferi loads in MBL deficient mice were observed in deeper tissue such as joint, heart and bladder. We 
have used B. burgdorferi N40 for both the needle inoculation and tick infestations experiments, which is a strain 
capable of inhibiting complement activation. It could be that MBL deficiency has a more significant impact on the 
survival of serum sensitive B. burgdorferi s.l. species such as B. garinii, but serum-sensitive B. garinii strains are, 
to the best of our knowledge, not able to establish an infection in immunocompetent laboratory mice. Indeed, in 
our hands B. garinii strain ZQ1, previously shown to be infectious in severe combined immunodeficiency (SCID) 
mice27, even at an inoculum as high as 107 spirochetes, was not capable of causing an infection in MBL deficient or 
WT C57BL/6 mice (data not shown). Identification of a serum sensitive strain capable of murine infection would 
be of great value for research on the role of complement during Borrelia burgdorferi s.l. infection.
MBL deficiency has also been linked to decreased disease burden as the result of decrease immune responses18. 
However, comparing inflammation in WT and MBL deficient mice, we found no differences in inflammation of 
skin six hours after inoculation. This suggests that influx of immune cells to the site of B. burgdorferi infection is 
not impaired in MBL deficient mice and can thus not explain the higher B. burgdorferi loads in skin at early time 
points in these mice compared to WT controls. In addition, inflammation in heart tissue was similar in both WT 
and MBL deficient animals 14 days after B. burgdorferi syringe inoculation. We chose to work with the C57BL/6 
genetic background based on the availability for MBL knockout mice. Importantly, the C57BL/6 genetic back-
ground of the mice is a genetic background known to be less susceptible for inflammation caused by B. burgdor-
feri infection28. Indeed, we could hardly find any signs of inflammation in skin or joint tissue (data not shown), 
despite confirmation of B. burgdorferi by qPCR and culture in these tissues. In the future, backcrossing MBL 
deficient mice to a more B. burgdorferi-susceptible C3H/HeN background could reveal whether MBL deficiency 
would result in a reduced inflammatory response during B. burgdorferi infection, although the extent of carditis 
was similar in WT and MBL deficient mice.
We have performed multiple in vitro experiments to identify the mechanism behind the observed increased B. 
burgdorferi survival at early time points in skin from mice lacking MBL. In vitro experiments using murine serum 
did not show impaired killing of a complement-sensitive B. garinii isolate by MBL deficient serum, as compared 
to WT serum. In addition, in our hands both WT and MBL deficient serum was able to inhibit outgrowth of the 
more complement-resistant B. burgdorferi N40, yet neither serum caused killing of B. burgdorferi N40 spirochetes 
as determined by dark field microscopy. Furthermore, cytokine production upon stimulation with B. burgdorferi, 
and phagocytosis by murine neutrophils in whole blood or by peritoneal macrophages was similar for WT and 
MBL deficient mice.
The discrepancy between human serum and murine serum in our previous and current experiments might 
be explained by the instability of murine complement, as described in literature29. Although we have taken the 
utmost precautions while obtaining and working with murine serum, i.e. freeze-thawing was avoided and serum 
was processed within a few hours after collection - the instability of murine complement, might have complicated 
our experiments. Murine complement instability might (partially) explain why murine MBL deficiency is ben-
eficial for B. burgdorferi survival in vivo, but not in vitro. Another explanation for the observed limited role of 
MBL is the fact that the complement system is an intricate system consisting of many different pathways that can 
initiate other innate immune responses. It could be that role of the lectin complement pathway is less important 
than the alternative or classical pathway in complement-mediated killing of Borrelia spirochetes, or that these 
pathways take over the role of the lectin pathway by initiating other innate immune responses in MBL deficient 
mice. Also, even within the lectin pathway itself, other components than MBL, such as ficolins or MASP-2, could 
have a compensatory role in the activation of the lectin pathway. This is supported by observations that TSLPI 
was also able to protect B. burgdorferi by inhibiting not only human MBL, but also L-ficolin. Further research is 
necessary to elucidate the role of MBL during B. burgdorferi infection as well as mechanisms that compensate 
innate immune responses in the absence of MBL.
To conclude, we assessed the role of MBL during B. burgdorferi infection in vivo and showed that MBL plays a 
role in survival of B. burgdorferi in the skin of the murine host in vivo. Our in vitro observations indicate that MBL 
is not crucial for murine complement dependent killing, cytokine production or phagocytosis of B. burgdorferi 
s.l. and we did not find evidence that influx of immune cells is impaired in MBL deficient mice compared to WT 
mice. Thus, the mechanism by which MBL facilitates early clearance of B. burgdorferi warrants further investi-
gation. Further research should focus on other complement factors that activate or modulate the lectin pathway.
Material and Methods
Mice. Experiments with ticks and mice were performed at Yale University, New Haven USA. All other animal 
experiments were performed at the Academic Medical Center (AMC) at Amsterdam, the Netherlands. Specific 
pathogen-free wildtype C57BL/6 mice and MBL-A and -C deficient C57BL/6 mice were purchased from Jackson 
Laboratories (Bar Harbor, ME)20. At the AMC, MBL null mice were bred in the animal facility of the Academic 
Medical Center (Amsterdam, The Netherlands). Age-and sex-matched animals were used in each experiment 
and the Animal Care and Use Committee of the University of Amsterdam approved all experiments (protocol 
number DIX102835). At Yale University, the animal experimental protocol was approved by the Yale University’s 
Institutional Animal Care & Use Committee (protocol number 2008–07941, approval date: 3/31/2014). All exper-
iments were performed in accordance with relevant guidelines and regulations.
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MBL serum levels in LB patients and healthy controls. Serum from LB patients with confirmed 
LB manifestations (EM, neuroborreliosis or ACA) or healthy controls previously collected at our institute were 
utilized for this analysis3,30. Wells (Microlon, Greiner) were coated with 10 mg/mL mannan overnight at 4 °C, 
blocked with 1% BSA in PBS. After blocking wells, serum dilutions (1:50 and 1:100) in wash buffer (TBS/Tween 
20/CaCl2) were added and incubated overnight at 4 °C. Wells were washed and incubated with monoclonal 
mouse anti-human MBL antibody (10 µg/mL, Sanquin, the Netherlands) in wash buffer for 1 hr at RT. After 
washing, HRP-conjugated anti-mouse IgG (1:4000) was added and incubated for 45 min at RT. The amount of 
MBL bound to the plates was determined by reading the absorbance at 450/655 nm using the iMark Microplate 
Reader (Bio-Rad). Concentrations were calculated by interpolation from a standard curve. 500 ng/mL was used 
as a cut-off for MBL deficiency15. All samples were tested in duplicate.
Murine B. burgdorferi infection by needle inoculation. To study the role of MBL in vivo, B. burgdorferi 
N40 spirochetes that were previously recovered from a bladder from a experimentally infected mice, were cul-
tured in modified Kelly medium (MKM) and 106 spirochetes in PBS were inoculated in the midline of the back, as 
described previously24. As a control, four mice were inoculated with only PBS. Mice were sacrificed at two weeks 
post-infection and skin (inoculation site), bladder, heart and tibiotarsi were collected and saved for histopatho-
logical examination, culture or qPCR, as described previously24. Serum was collected (see below) for IgG and IgM 
assessment. DNA from the organs was extracted using the Qiagen Blood and Tissue kit and B. burgdorferi loads 
were subjected to quantitative B. burgdorferi flaB PCR normalized for quantitative mouse β-actin PCR. To assess 
carditis, five µm-thick paraffin embedded sections of sagittally dissected hearts were processed and stained with 
hematoxylin and eosin by routine histological techniques. Carditis was scored on a scale from 0 to 3 by a pathol-
ogist blinded to the experimental design, as previously described24.
Detection of B. burgdorferi IgG and IgM levels in murine serum. B. burgdorferi N40 specific IgG and 
IgM in murine serum from mice infected with B. burgdorferi N40 were measured by ELISA, as described previ-
ously24. Briefly, wells were coated with B. burgdorferi N40 lysate (1 µg/mL) and bound IgG and IgM was detected 
with respectively anti-mouse IgG and anti-mouse IgM HRP (both 1:2000). Serum from mice injected with PBS 
was used as a control and all measurements were performed in duplicate.
B. burgdorferi infection by I. scapularis tick infestation. Four B. burgdorferi N40 infected nymphs 
per mice were placed on eight MBL deficient or eight WT control mice, as described previously31. Nymphs were 
allowed to feed to repletion. DNA was isolated from skin punch-biopsies at day 7 and 21 and from heart and 
joints at day 21. B. burgdorferi burden was assessed by qPCR, as described above. Two separate experiments were 
performed, one with three animals per group and one with five animals per group and the results were pooled.
Binding of recombinant human MBL to B. burgdorferi. Binding of MBL to B. burgdorferi N40 was 
essentially performed as previously described32. Cultured 2 × 108 spirochetes/mL B. burgdorferi N40 were incu-
bated with 5 µg/mL recombinant human MBL (R&D systems, Minneapolis, MN) for 30 minutes at 37 °C in 
HBSS with 5 mM CaCl2 and 5 mM MgCl2. As a control, medium with 100 mM EDTA was used. Spirochetes 
were washed and bound MBL was detected using mouse anti-human MBL (1:250) (mAb 3E7, Hycult-biotech, 
Uden, the Netherlands) and goat anti-mouse IgG Texas Red (1:1000, Invitrogen, CA, USA). Spirochetes were 
fixated using 4% PFA and MBL binding was measured by flow cytometry performed on a FACS Canto (Becton 
Dickinson).
Binding of murine MBL to B. burgdorferi lysate. B. burgdorferi membrane extract33 was coated (10 µg/
mL) on high binding microtiter plates (Microlon, Germany) overnight. Wells were blocked with PBS/1% BSA 
at RT for 1 h and incubated with normal murine serum, MBL deficient murine serum or normal murine serum 
pre-incubated with 100 mM EDTA, diluted from 1:25 to 1:3200 in PBS/0.05% Tween20/1% BSA. After 1 h, cells 
were washed and incubated with 1:500 rat anti-MBL-A IgG (mAb 8G6, Hycult-biotech, Uden, the Netherlands) 
and bound antibody was detected using HRP-conjugated anti-rat IgG (H&L) (Abcam, United Kingdom) and 
TMB as substrate (Thermoscientific, IL).
Killing of B. burgdorferi and B. garinii by murine serum. Murine serum was collected from blood of 
WT and MBL deficient C57BL/6 mice via cardiac puncture. Since murine serum is highly unstable, experiments 
were started within 2 h after blood was collected in glass tubes at RT. Thirty minutes after collection, blood was 
centrifuged at 3000 g for 7 minutes and serum was collected and centrifuged again at 20000 g for 5 minutes at RT 
as previously described29. Complement-dependent growth inhibition was assessed, as previously described12,23. 
Briefly, B. burgdorferi N40 or B. garinii A87S (2 × 107) were resuspended in 100 μl BSK-H medium containing 
240 μg/mL phenol red with 50% murine serum (WT or MBL deficient serum) for 2 h at 37 °C. As a control, B. 
burgdorferi was resuspended in with 50% heat-inactivated murine serum. Samples were subsequently incubated 
at 33 °C for five days and growth of B. burgdorferi was determined by measuring the OD at 562/630 nm each 24 h 
using the Biotek Synergy HT plate reader. Each sample was performed in triplicates and the experiment was per-
formed twice. For assessment of dead (non-motile) spirochetes by dark-field microscopy, spirochetes were added 
to a 96 well cell culture plate (107/mL) and supplemented with 25% serum (B. garinii A87S) or 50% serum (B. 
burgdorferi N40), incubated at 37 °C and a 5 μL sample was observed under dark field microscopy, by a researcher 
blinded for the experimental design, for spirochete motility as described earlier34. Heat-inactivated serum was 
used as a control. Each sample was performed in triplicates and the experiment was performed three times.
In vitro inflammatory cytokine response upon stimulation with B. burgdorferi. Whole blood 
from five naive MBL knock-out or WT mice were obtained from cardiac puncture and was collected in 
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heparinized tubes. Whole blood was stimulated in 96-well microtiter plates (Greiner) with B. burgdorferi N40 
(MOI: 5) suspended in RPMI medium with FCS and L-glutamine. RPMI medium without spirochetes was used 
as a control. Samples were incubated for 16 h at 37 °C and 5% CO2. Supernatants were collected and cytokine 
production was measured by a mouse inflammation cytometric bead array (BD, NJ, USA). For the cytokine 
production by murine macrophages, peritoneal macrophages were harvested from WT mice by peritoneal lav-
age as described elsewhere35. Adherent peritoneal macrophages (50.000) in Greiner 96-well plates were washed 
with RPMI twice. B. burgdorferi was added to a MOI of 5 in RPMI with 20% WT serum or MBL deficient serum 
(pooled sera from five mice). Samples without serum and samples with serum but without spirochetes were used 
as an control. Samples were incubated for 16 h at 37 °C and 5% CO2. Supernatants were collected and cytokine 
production was measured by CBA. All samples were performed in triplicates and both experiments were per-
formed twice.
phagocytosis by whole blood or murine macrophages. Phagocytosis assays were performed in 
essence as described before12,24. Murine whole blood obtained from cardiac puncture from was collected in hepa-
rinized tubes. CFSE-labeled viable B. burgdorferi (3 × 108 spirochetes/mL in 25 µL, MOI:10) was added to 125 µL 
murine whole blood. All materials were kept on ice until all samples were ready. Samples were incubated in a 
37 °C water bath and at 5, 15 and 30 minutes 30 µL from each sample was added to 4 mL ice-cold FACS buffer 
(PBS, 5% bovine serum albumin (BSA), 0,01% NaN3 and 0,35 mM EDTA). Samples continuously kept on ice 
were used as a control. Subsequently, samples were incubated in erythrocyte lysis buffer for 20 minutes. Samples 
were washed and incubated with anti-Ly6-PE antibodies for 30 minutes. Phagocytosis of B. burgdorferi by neu-
trophils were visualized on the FACS Canto (Beckton Dickinson) and the phagocytosis index of neutrophils in 
each sample was calculated as mean fluorescence intensity (MFI) × percentage CFSE-positive at 37 °C minus 
the phagocytosis index of samples kept on ice. Each sample and each time point were performed in triplicates 
and the experiment was performed twice. Phagocytosis by peritoneal macrophages (see above) was assessed in 
essence as described above. Adherent peritoneal macrophages (50.000) in Greiner 96-well plates were washed 
with RPMI and stimulated with CFSE-labeled B. burgdorferi N40 (MOI: 25) in the presence of 10% WT serum 
or MBL deficient serum. After 30 minutes, the supernatant was removed and cells were washed twice, collected 
and processed for analysis by flow cytometry. Samples kept on ice were used as a control. The experiment was 
performed in triplicate.
In vivo migration in murine skin. To assess influx of immune cells at the site of infection, we intrader-
mally injected C57BL/6 WT and KO mice with 1 × 106 B. burgdorferi in PBS in the midline of the neck and mice 
were sacrificed 6 hours post inoculation, as previously described24. Control animals were injected with PBS. The 
experiment was performed twice, one time with 8 mice per group and 4 controls and one time with 6 mice per 
group and 2 controls. Skin was harvested, formalin fixed and imbedded in paraffin. Five µm-thick sagittal skin 
sections were processed and H&E stained by routine histological techniques. Slides were scored on a scale from 
0–3 for inflammation by an independent pathologist who was blinded to the experimental, with 0 being no, 1 
mild, 2 moderate, and 3 being severe diffuse infiltration. Of each mouse, the average score of two slides was used.
statistical analysis. The significance of the difference between the mean values of the groups was analyzed 
using Prism 5.0 software (GraphPad Software, San Diego, CA). A two-tailed non-parametric Mann-Whitney test 
was used and a p-value of < 0.05 was considered significant.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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